Ensysce Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical ...

25.04.2024 - ~ Dr. Kirkpatrick Leads the Company's Unique Response to Effectively Reduce Prescription Drug Overdose and Abuse ~SAN DIEGO, CA / ACCESSWIRE / April 25, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ('Ensysce' or the 'Company'), a clinical stage ... Seite 1

Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) and Ensysce Biosciences (NASDAQ:ENSC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Valuation & Earnings This table compares Abeona […]

Ensysce Biosciences (NASDAQ:ENSC – Free Report) had its target price lowered by HC Wainwright from $9.00 to $7.00 in a research report sent to investors on Monday morning, MarketBeat.com reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Ensysce Biosciences’ Q3 2023 earnings at ($0.93) EPS, Q4 […]

Ensysce Biosciences (NASDAQ:ENSC – Get Free Report) and GH Research (NASDAQ:GHRS – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Valuation and Earnings This table compares Ensysce Biosciences […]